相关实验视频

Updated: May 20, 2025

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

在初级开角青光眼中探索诊断m6A调节器:从基因特征和关键基因功能可能机制的洞察力

Xinyue Zhang^1,2, Jiawei Chen^1,2, Xiaoyu Zhou^1,2

¹Hunan Engineering Research Center for Glaucoma with Artificial Intelligence in Diagnosis and Application of New Materials, Glaucoma Institute, Changsha Aier Eye Hospital, Changsha, Hunan, China.

BMC medical genomics

|March 25, 2025

概括

包括YTHDC2在内的N6-甲基氨酸 (m6A) 调节剂通过影响状网细胞迁移和细胞外矩阵合成,在初级开角青光眼 (POAG) 中发挥作用. 这些调节剂可以作为POAG.的诊断生物标志物.

科学领域:

眼科医生眼科眼科
分子生物学分子生物学
表观遗传学在表观遗传学中,表观遗传学是指表观遗传学.

背景情况:

主要开角青光眼 (POAG) 是不可逆转失明的主要原因.
椎间板状网络 (TM) 功能障碍是POAG发病的一个关键因素.
在POAG中,N6-甲基氨酸 (m6A) 调节剂在TM组织损伤中的作用仍未得到充分研究.

研究的目的:

研究m6A调节器在POAG患者TM组织损伤中的参与.
在m6A调节者中识别POAG的潜在诊断生物标志物.

主要方法:

在POAGTM组织中对m6A调节器表达的生物信息分析.
在体外实验中使用人类TM细胞 (HTMCs) 与操纵YTHDC2表达 (等离子体转染,siRNA) 的实验.
评估细胞迁移 (特兰斯威尔试验) 和细胞外矩阵 (ECM) 蛋白质表达 (免疫光).

主要成果:

确定了五种差异表达的m6A调节剂作为POAG.的潜在诊断生物标志物.
在氧化应激和TGF-β2刺激下,YTHDC2mRNA的表达水平在HTMC中发生变化.
沉默YTHDC2增强了HTMC迁移和ECM合成;一个缺乏YTH域的YTHDC2突变并没有影响ECM合成.

结论:

不同表达的m6A调节剂,特别是YTHDC2,涉及POAG病原性.
通过m6A修饰,YTHDC2影响TM细胞迁移和ECM合成,表明其作为治疗点的潜力.
m6A调节器可以作为POAG.宝贵的诊断生物标志物.

关键词:

眼光障碍症眼光障碍症眼光障碍症这是一种N6-甲基氨酸.氧化应激是一种氧化应激.波阿格 (POAG) 是一个脊柱状的网状网状网状网状网状网.

更多相关视频

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

Published on: March 23, 2016

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

相关概念视频

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...